Advertisement
"Automating our recently expanded Phase I facility with ALPHADAS willenable us to provide our Pharma and Biotech sponsors with top quality, realtime access to critical data while conducting state-of-the-art clinicaltrials." - Azhar Kalim, COO of Qualia Clinical Services, Inc.
Advertisement
"We are committed to helping our clients accelerate their time-to-market.We decided to re-evaluate the market because our previous EDC vendor was notmeeting our business needs. We chose industry leading ALPHADAS to achieve ouroperational goals." - Dr. Sohail Khattak, CEO/President and CSO.
Logos Technologies has been providing early phase EDC and clinical siteautomation tools to the pharmaceutical industry for over 12 years. "We aredelighted to welcome Qualia Clinical Services as a new client and value thisopportunity to facilitate its operational goals," said Giles Wilson, BEng,co-founder of Logos Technologies. "The partnership will help our mission tobecome the world's leading early phase EDC and clinical trial automationcompany, assisting organizations to reduce the development time oflife-saving and life-enhancing drugs."
The rapid success of Qualia's Phase I facility, which opened in the fallof 2006, necessitated the recent addition of 10,000 square feet. The clinicnow boasts a total of 33,000 square feet, a bed capacity of over 160 beds andmore than 150 professional staff. Additionally, administrative, operationaland recreational areas were completely redesigned to better serve clients andstudy participants. Qualia Clinical Services, is changing lives for thebetter by providing its partners in the clinical research industry the fullcapabilities to complete early and late phase clinical trials. A full servicecontract research organization, Qualia has state-of-the-art clinicaloperations in Omaha, Nebraska , Toronto, Canada and Kiev, Ukraine. Moreinformation about Qualia can be obtained through its website athttp://www.qualiaclinical.com
Logos Technologies is a leading provider of world-class integratedclinical trial solutions to the world's pharmaceutical, biotechnology andclinical research organisations. ALPHADAS is a clinical study management andfully mobile early Phase proactive EDC system that has been designed for realtime eSource data collection. The system provides time based data entry atthe bedside, collection and integration of laboratory data, images and scansand Bar-coded labeling to track samples from draw to dispatch. LogosTechnologies established and proven product ALPHADAS sets the standard incollecting early Phase clinical trial data. ALPHADAS is fully compliant withindustry standards and guidelines including FDA 21 CFR Part 11. Moreinformation about Logos Technologies can be obtained through its website athttp://www.logostechnologies.com
For more information contact Angela King, Logos Technologies Ltd,+44(0)8707-478900
http://www.logostechnologies.com, http://www.qualiaclinical.com
SOURCE Logos Technologies
